Assuta Medical Center
Testicular cancer treatment cost in Israel is largely determined by the disease stage and required therapies, with a PET-CT scan typically ranging from $1,300 to $1,800. While specific surgical costs vary, initial oncologist consultations run from $400 to $600. Total expenses depend on the complexity of the case and the clinic tier, often offering 20-40% savings compared to the US. Top treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Testicular Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients seeking high-precision care should consider Sourasky Medical Center, which reports a 90% oncology success rate. For complex urological cases, experts like Dr. David Sarid offer specialized UK-trained expertise in cancer urology. Private options like Assuta Medical Center provide the highest flexibility for surgery scheduling. Early-stage patients benefit most from the rapid diagnostic tracks available at these JCI-accredited facilities.
| Izrael | Turcja | Austria | |
| Proteza jądro | od $6,500 | od $1,500 | od $3,500 |
| Orchidektomia | od $5,800 | od $2,889 | od $9,000 |
| Chemioterapia w raku piersi | od $22,500 | od $1,200 | od $15,000 |
| Usunięcie guza jądra | - | od $4,500 | od $8,500 |
| Radioterapia raka odbytnicy | - | od $7,000 | od $12,000 |
Prof. Merimsky kieruje Oddziałem Onkologii Tkanek Miękkich i Kości w Centrum Medycznym Sourasky, koncentrując się na rzadkich nowotworach.
Dr Sarid kieruje oddziałem onkologii, urologii i radioterapii w Centrum Medycznym Ichilov. Posiada on bogate doświadczenie w leczeniu raka jąder.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.